Related Experiment Videos
Minimally invasive orbital decompression for Graves' ophthalmopathy
Marmar Vaseghi1, Thomas T Tarin, Peter S Levin
1Division of Otolaryngology-Head and Neck Surgery, Stanford University Medical Center, Stanford, California, USA.
The Annals of Otology, Rhinology, and Laryngology
|January 23, 2003
Summary
Minimally invasive orbital decompression effectively treats Graves' ophthalmopathy, improving vision and reducing proptosis. This safe surgical approach offers significant benefits for patients with this endocrine eye disease.
Area of Science:
- Ophthalmology
- Endocrinology
- Neurosurgery
Background:
- Graves' ophthalmopathy causes vision-threatening complications and disfigurement due to orbital tissue expansion.
- Surgical intervention, specifically orbital decompression, is a key treatment modality for managing severe cases.
Purpose of the Study:
- To evaluate the efficacy and safety of minimally invasive orbital decompression for Graves' ophthalmopathy.
- To define the surgical goals, potential risks, and clinical outcomes in a tertiary-care setting.
Main Methods:
- A retrospective review of 7-year surgical experience with endoscopic medial, lateral, and inferior orbital decompression.
- Procedures included septoplasty, turbinate reduction, and orbital rim augmentation as needed.
- Indications for surgery were vision threat (n=10) and rehabilitative proptosis reduction (n=16).
Main Results:
- Significant reduction in exophthalmos (mean 4.4 mm, p < .001).
- All patients with vision threat experienced improved visual acuity post-surgery.
- Low complication rate, including transient diplopia (n=3) and sinusitis (n=1).
Conclusions:
- Minimally invasive orbital decompression is an effective and relatively safe surgical option for Graves' ophthalmopathy.
- The procedure successfully addresses both vision-threatening complications and cosmetic concerns.
- Modern decompression techniques offer favorable outcomes with manageable risks.